lonsurf
les laboratoires servier - trifluridine, tipiracil υδροχλωρική - Πρωτοπλαστικά νεοπλάσματα - Αντινεοπλασματικοί παράγοντες - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
oxaliplatin/medac 5mg/ml pd.sol.inf
medac gesellschaft fur klinische spezialpraparate mbh - oxaliplatin - ΚΟΝΙΣ ΓΙΑ ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ - 5mg/ml - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
capecitabine/mylan 150mg/tab επικαλυμμενο με λεπτο υμενιο δισκιο
mylan s.a.s., saint priest, france (0000008105) 117 allee des pares, 69800, saint priest - capecitabine - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 150mg/tab - ineof01439 capecitabine 150.000000 mg - capecitabine
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - Νεοπλάσματα του στομάχου - Αντινεοπλασματικοί παράγοντες - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
capecitabine remedica 500mg film coated tablets
remedica ltd (0000003171) aharnon str., lemesos, 3056 - capecitabine - film coated tablets - 500mg - capecitabine (8000001774) 500mg - capecitabine
capecitabine remedica 150mg film coated tablets
remedica ltd (0000003171) aharnon str., lemesos, 3056 - capecitabine - film coated tablets - 150mg - capecitabine (8000001774) 150mg - capecitabine
cetirizine 10mg film coated tablets
mylan sas - ΥΔΡΟΧΛΩΡΙΔΙΟ ΚΑΤΗΡΙΖΙΝΗΣ - film coated tablets - 10mg - 0083881521 - cetirizine hydrochloride - 10 mg - cetirizine
refalin 300mg/150mg film coated tablets
remedica ltd (0000003171) aharnon str., lemesos, 3056 - isoniazid; rifampicin - film coated tablets - 300mg/150mg - isoniazid (0000054853) 150.000000000000mg; rifampicin (0013292461) 300.000000000000mg - rifampicin, combinations
rifasynt 300mg capsule,hard
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - rifampicin - capsule,hard - 300mg - rifampicin (0013292461) 300mg - rifampicin
rifasynt 150mg capsule,hard
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - rifampicin - capsule,hard - 150mg - rifampicin (0013292461) 150mg - rifampicin